Clinical Trial Update: Dopaminergic Dysfunction in Late-Life Depression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from Vanderbilt University Medical Center is investigating dopaminergic dysfunction in late-life depression and its relationship to cog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Late-life Depression
• Treatment-resistant Depression

Drugs mentioned

• levodopa (levodopa)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Late Life Depression, Cognitive Decline | Phase 2 | Status: ACTIVE_NOT_RECRUITING